文献速递关节外科

无髌骨置换的原发性全膝关节置换术中超形合度与后交叉韧带保留聚乙烯衬垫的髌骨相关翻修风险无差异:澳大利亚登记研究42,105例膝关节置换

No Increased Risk of Patella-Related Revisions When Comparing Ultra-Congruent versus Cruciate-Retaining Polyethylene Liners in Primary Total Knee Arthroplasties With an Unresurfaced Patella: An Australian Registry Study of 42,105 Knee Arthroplasties.
PubMed 文献 · J Arthroplasty · 2024-11-16

基于澳大利亚骨科协会国家关节置换登记系统的回顾性队列分析,纳入2007年1月1日至2022年12月31日期间因骨关节炎行初次全膝关节置换且未行髌骨置换的42,105例手术(超形合度衬垫组18,989例,后交叉韧带保留衬垫组23,116例)。结果显示两组14年累积翻修率分别为后交叉韧带保留组5.7%(95%CI 4.7-6.9)和超形合度组5.4%(95%CI 4.8-6.1),全因翻修风险无差异(HR=1.07,95%CI 0.95-1.20,P=0.256),髌骨相关翻修风险亦无差异(HR=1.10,95%CI 0.88-1.38,P=0.406)。作者结论认为超形合度衬垫未增加全因或髌骨相关翻修率。

要点

  • 14年累积翻修率:后交叉韧带保留组5.7% vs 超形合度组5.4%,全因翻修HR=1.07(95%CI 0.95-1.20,P=0.256),无差异。
  • 髌骨相关翻修风险:后交叉韧带保留组 vs 超形合度组HR=1.10(95%CI 0.88-1.38,P=0.406),无差异。
  • 假体特异性分析中两组全因翻修或髌骨相关翻修均无差异。

核心结论

  • 在未行髌骨置换的原发性全膝关节置换术中,使用超形合度衬垫与后交叉韧带保留衬垫相比,未增加全因翻修率或髌骨相关翻修率。
  • 作者认为,外科医生应基于其他患者、手术和假体因素来决定是否需要行髌骨置换。

研究设计与样本

  • 回顾性队列分析,数据来自澳大利亚骨科协会国家关节置换登记系统。
  • 纳入2007年1月1日至2022年12月31日期间因骨关节炎行初次全膝关节置换、采用两种常用膝关节系统之一且胫骨固定为骨水泥固定、未行髌骨置换的患者。
  • 共纳入42,105例初次全膝关节置换,其中超形合度衬垫组18,989例,后交叉韧带保留衬垫组23,116例。

主要发现

  • 14年累积翻修率:后交叉韧带保留组5.7%(95%CI 4.7-6.9)vs 超形合度组5.4%(95%CI 4.8-6.1)。
  • 全因翻修风险:后交叉韧带保留组 vs 超形合度组整个研究期间HR=1.07(95%CI 0.95-1.20),P=0.256,无差异。
  • 髌骨相关诊断翻修风险:后交叉韧带保留组 vs 超形合度组整个研究期间HR=1.10(95%CI 0.88-1.38),P=0.406,无差异。
  • 假体特异性分析中,两组全因翻修或髌骨相关翻修均无差异。

临床怎么用

  • 作者认为,外科医生应基于其他患者、手术和假体因素来决定是否需要行髌骨置换。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ultra-congruent (UC) polyethylene liners are designed to add additional anterior-posterior stability in primary total knee arthroplasties (TKAs), compensating for actual or potential posterior cruciate ligament incompetence, somewhat like a posterior-stabilized knee. The literature supports patella resurfacing in primary posterior-stabilized compared to cruciate-retaining (CR) TKA due to higher revision rates with nonresurfaced patella. However, it is unclear if UC liners alter patella-related revisions. The aim of the study was to compare patella revision rates and survivorship of UC versus CR liners in primary TKA without patella resurfacing using two common prostheses in patients who had osteoarthritis. METHODS: This was a retrospective cohort analysis of data from the Australian Orthopedic Association National Joint Replacement Registry. Patients who underwent primary TKA utilizing one of two common knee systems with cemented tibial fixation for osteoarthritis and did not have their patella resurfaced between January 1, 2007, and December 31, 2022, were included for analysis. A total of 42,105 primary TKA procedures were included (UC, n = 18,989 and CR, n = 23,116). The risk of patella-related revision and survivorship for primary TKA procedures with UC compared to CR liners were analyzed. RESULTS: The cumulative revision at 14 years was 5.7% (95% confidence interval [CI] 4.7 to 6.9) and 5.4% (95% CI 4.8 to 6.1) for the CR and UC group, respectively, with no difference between groups (entire period: HR [hazard ratio] = 1.07 (95% CI 0.95 to 1.20), P = 0.256). When revision TKA for patella-related diagnoses was analyzed, there was no difference between the CR and UC groups (entire period: HR = 1.10 (95% CI 0.88 to 1.38), P = 0.406). The prosthesis-specific analyses did not produce any differences between the groups for all-cause or patella-related revisions. CONCLUSIONS: The use of UC compared to CR liners in primary TKA without patella resurfacing was not associated with an increased rate of all-cause or patella-related revisions. Surgeons should make clinical decisions on the need for patella resurfacing based on other patient, surgical, and implant factors.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Onggo JR, Holder C, McAuliffe MJ, et al. No Increased Risk of Patella-Related Revisions When Comparing Ultra-Congruent versus Cruciate-Retaining Polyethylene Liners in Primary Total Knee Arthroplasties With an Unresurfaced Patella: An Australian Registry Study of 42,105 Knee Arthroplasties. J Arthroplasty. 2024. PMID: 39551405. doi:10.1016/j.arth.2024.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。